Ocular Drug Delivery Technology Market
Ocular Drug Delivery Technology Market Analysis By Type (Topical, Ocular, Iontophoresis), By Formulation (Solution based, Suspension based, Emulsion based), By Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome), By Region - Global Insights 2022-2032
Analysis of Ocular Drug Delivery Technology market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Ocular Drug Delivery Technology Industry Overview (2022-2032)
The global ocular drug delivery technology market is likely to be valued at US$ 17.74 Billion in FY 2022, up from US$ 16.4 Billion in 2021.
| Report Attributes | Details |
|
Anticipated Base Year Value (2021) |
US$ 16.4 Billion |
|
Expected Market Value (2022) |
US$ 17.74 Billion |
|
Projected Forecast Value (2032) |
US$ 39 Billion |
|
Global Growth Rate (2022-2032) |
8.2% CAGR |
|
Growth Rate of the U.S Market (2022-2032) |
7.1% CAGR |
|
Expected Market Value of China (2032) |
US$ 3.5 Billion |
|
U.K Market Expansion Rate (2022-2032) |
7.2% CAGR |
|
Key Companies Profiled |
|
During the past year, the industry registered a Y-o-Y increase worth 8.2%. From 2022 to 2032, the ocular drug delivery technology industry is poised to flourish at a CAGR of 8.2% to reach a value of US$ 39 Billion by the end of 2032.
Demand for liposome and nanoparticle formulations will continue to thrive, with a documented CAGR of 8.2% during the 2015-2021 historical period of assessment, while demand for intraocular implants Ocular Drug Delivery Technology proliferated at a rate of 7.7% during the same time period.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
2015 to 2021 Ocular Drug Delivery Technology Market Revenue Analysis vs. Market Outlook 2022-2032
According to Fact.MR, the sales of ocular drug delivery system have propagated at a 7.2% CAGR between 2015 and 2021. Ocular drug delivery systems are platforms invented for dispensing drug, biologic, biopharmaceutical, and botanical therapeutics for doctoring macular degeneration, glaucoma, presbyopia, allergy, anti-viral, dry eye, anti-infective and anti-inflammatory indications.
It is anticipated that glaucoma cases will surpass 100 billion by 2040, while macular degeneration shall reach nearly 200 billion by 2022-end. These increasing cases are poised to heighten prospects for the ocular drug delivery technology. Immense research and development are occurring in the ocular drug delivery market. Shortages in the bioavailability of such drugs is a key growth driver. Studies have shown that micellar formulations and derivative active pharmaceutical ingredients have immense scope for development. Based on these trends, the global ocular drug delivery technology market is poised to register positive growth.
To beat the ocular drug delivery barriers and advance bioavailability, numerous conventional and new drug delivery systems have been established such as ointments, emulsion, suspensions, aqueous gels, nanomicelles, liposomes, dendrimers, implants, contact lenses, nanoparticles, Nano suspensions, microneedles, and in situ thermosensitive gels for the earlier mention ocular diseases.
Key Drivers Stimulating Ocular Drug Delivery Technology Industry Expansion
Advancement in Medical Assistance & Prevalence of Vision Impairment to Act as key Drivers
Recently, there has been an increment in the geriatric population followed by upsurge in occurrence of eye disease such as glaucoma, cataract and macular degeneration, augmenting the demand of ophthalmic drug in countries like U.S & Canada.
A latest published report by National Institute for Occupational Safety & Health (NIOSH) summarizes that nearly 2,000 workers need medical assistance owing to job-related eye injuries every day in the United States. Similarly, over 12 billion people aged above 40 years have vision impairment in the nation. Therefore, the demand for effective treatment to control the increasing incidence of ophthalmic diseases and injuries is likely to create a pool of growth opportunities for the foresaid market.
Promising reimbursement strategies and ongoing advancement in drug delivery treatment will proliferate the growth of ocular drug delivery technology system. Swelling demand for targeted drug delivery techniques will fortify the ocular drug delivery technology system market growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Key Challenges to Ocular Drug Delivery Technology Industry Expansion
Expensive Cost of Production & Drug-related Side effects to Restrain Market Expansion
Based on the recent analysis, prominent drug manufacturer which hinders the market growth of ocular drug delivery technology which comprises excessive cost and complexities linked with the treatment. Low bioavailability of drugs for conventional ocular therapies is also one of the prominent restraining factors in the ocular drug delivery system market.
Subsequently after the clinical trials, scientists have discovered some side effects of ocular drug delivery technology on the human skin such as irritation, excessive lachrymation, and drug dilution occurring post the treatment which is expected to restrict the market growth over the forecast period.
Country-wise Analysis
How Opportunistic are Growth Prospects across the U.S Market?
Presence of Prominent Manufacturers Reinforce the Demand for Ocular Drug Delivery System
North America is poised to retain hegemony in the global ocular drug delivery technology market. Burgeoning cases of visual impairments, high cost of ocular surgeries and presence of a large number of market players are anticipated to boost the North American market. Canada will arise as the fastest growth market within North America, yet the U.S. is estimated to remain dominant through the assessment period.
There are approximately 3 Billion people with glaucoma and between 16 and 49 Billion people suffering from dry eyes in the United States alone. Rise in patients suffering from infections or inflammatory diseases (uveitis), and that is a significant number of people who have to administer eye drops regularly
Projections indicate a market share exceeding half of the total ocular drug delivery technology market. In addition, introduction of different formulation types and reduced research and development costs are also poised to leverage growth prospects. Fact.MR forecasts that the North American market is anticipated to expand 1.4x to surpass US$ 9 Billion during the forecast period. The market is subjected to register a CAGR value of 7.1% which documented a valuation of nearly US$ 4.2 Billion in 2021.
Why are Ocular Drug Delivery Technology Providers Venturing into China?
Amplifying Pharmaceutical Growth in China to Reinforce the Foresaid Market Demand
Asia-Pacific is expected to generate credible growth opportunities in the future. Establishment of research and development units by key manufacturers in emerging economies, increasing prevalence of cataract and uveitis are key growth levers. Research grants are being advanced by major research companies across several Asia-Pacific countries, thus broadening the scope of drug development. The Asia-Pacific region is poised to expand at a CAGR of 7% throughout the forecast period, capturing nearly 1/10th of the total market share.
With upsurge in disposable income, the emerging nations like China & India are continuing to spend on ground-breaking technologies for better treatment modalities. China is already the second largest pharma market in the world, but as drug makers encounter growth challenges in the U.S. and other established countries, the country is looking more alluring in the current scenario. Fact.MR’s latest report summarizes that APAC ocular drug delivery technology market is estimated to surpass US$ 3.5 Billion, following a CAGR of 7.3% throughout the conjecture period.
Country-wise Value CAGRs for Ocular Drug Delivery Technology (2022-2032)
|
U.S |
7.1% |
|
U.K |
7% |
|
China |
7% |
|
Japan |
7.4% |
Category-wise Insights
Which Product Type is Most Preferred in the Ocular Drug Delivery Technology Market?
Solution-based Formulations to Remain Most Preferred across the Globe
By formulation type, solutions are anticipated to capture the majority share, accounting for more than 60% of the global ocular drug delivery technology market. High production volume, high-patient compliance and cost-effectiveness are important growth levers.
Augmenting demand for targeted drug delivery, especially for posterior eye disorders, and high penetration of low molecular size particles shall leverage market prospects for liposome and nanoparticle formulations. Moreover, nanoparticles are claimed to provide prolonged resistance time on the ocular surface. Fact.MR reveals that liposome and nanoparticle segment have recorded a CAGR of 8.2% in the historic period, reaching a value of US$ 1.75 Billion by 2032-end.
By technology, which Ocular Drug Delivery Technology is expected to Dominate?
Pharmaceutical Advancements in Developing Regions to Spur Demand for Intraocular Implants
In terms of technology advancements, the intraocular implants segment is witnessing the fastest-growth rate in the upcoming future. High adoption of intraocular implants due to its targeted action and long-term effectiveness have boosted growth opportunities for this technology. A market share of more than one-tenth is anticipated for intraocular implants, expanding at a CAGR of 7.7% across the forecast period. The segment is poised to reach a value of US$ 3.6 Billion by the end of conjecture period.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Prominent Ocular Drug Delivery Technology providers are reliant on partnerships, collaborations, acquisitions, and new software launches so as to stay afloat in the global market. Constant innovations to ensure a seamless client-customer relationship are the main focus of prominent market players.
- In Feb 2022, Alimera Sciences, Inc., a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that Alimera Sciences Europe Limited, its Ireland-based European subsidiary, launched ILUVIEN® for non-infectious posterior uveitis in Spain, through its distribution partner, Brill Pharma (Brill).
- In October 2021, Allergan, an AbbVie company, announced that it will present new pooled analyses and post hoc results from the Phase 3 trials of AGN-190584 (pilocarpine HCl ophthalmic solution 1.25%), an investigational novel treatment for presbyopia, at Academy 2021, the annual meeting of the American Academy of Optometry, November 3-6. Presentations included the clinical results for near and intermediate vision, functional near vision, efficacy for post-LASIK patients, and the patient experience.
Key Segments Covered in the Ocular Drug Delivery Technology Industry Survey
-
Ocular Drug Delivery Technology by Type :
- Topical Ocular Drug Delivery Technology
- Ocular Drug Delivery Inserts:
- Non-erodible Ocular Drug Delivery Technology
- Erodible Ocular Drug Delivery Technology
- Iontophoresis Ocular Drug Delivery Technology
- Intraocular Implants:
- Biodegradable Ocular Drug Delivery Technology
- Non-biodegradable Ocular Drug Delivery Technology
- In-Situ Gel & Punctal Plugs Ocular Drug Delivery Technology
- Others
-
Ocular Drug Delivery Technology by Formulation :
- Solution based Ocular Drug Delivery Technology
- Suspension based Ocular Drug Delivery Technology
- Emulsion based Ocular Drug Delivery Technology
- Liposomes & Nanoparticles based Ocular Drug Delivery Technology
- Ointment based Ocular Drug Delivery Technology
-
Ocular Drug Delivery Technology by Disease Type :
- Ocular Drug Delivery Technology for Glaucoma
- Ocular Drug Delivery Technology for Diabetic Retinopathy
- Ocular Drug Delivery Technology for Dry Eye Syndrome
- Ocular Drug Delivery Technology for Macular Degeneration
- Ocular Drug Delivery Technology for Diabetic Macular Edema
- Ocular Drug Delivery Technology for Cataract
- Others
-
Ocular Drug Delivery Technology by Region :
- North America Ocular Drug Delivery Technology Market
- Latin America Ocular Drug Delivery Technology Market
- Europe Ocular Drug Delivery Technology Market
- Asia Pacific Ocular Drug Delivery Technology Market
- Middle East & Africa Ocular Drug Delivery Technology Market
Table of Content
1. Preface 1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Ocular Drug Delivery Disease Type Market 4. Market Overview 4.1. Introduction 4.1.1. Disease Type Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Key Market Indicators 4.3.1. Region/Country Specific 4.3.2. Product/Application/Disease Type Specific 4.3.3. Target Market Specific – Global Scenario 4.4. Market Dynamics 4.4.1. Drivers 4.4.2. Restraints 4.4.3. Opportunity 4.5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, 2022-2032 4.6. Ocular Drug Delivery Disease Type Market - Global Supply Demand Scenario 4.7. Porter’s Five Force Analysis 4.8. Market Outlook 4.9. Ocular Drug Delivery Technology: Pipeline Analysis 5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type 5.1. Introduction & Definition 5.2. Key Findings / Developments 5.3. Key Trends 5.4. Market Value Forecast By Disease Type, 2022-2032 5.4.1. Topical 5.4.2. Ocular Insert 5.4.2.1. Erodible 5.4.2.2. Non-Erodible 5.4.3. Iontophoresis 5.4.4. Intraocular Implant 5.4.4.1. Biodegradable 5.4.4.2. Non-Biodegradable 5.4.5. In Situ Gel & Punctal Plug 5.4.6. Others 5.5. Market Attractiveness By Disease Type 6. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Formulation Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Key Trends 6.4. Market Value Forecast By Formulation Type, 2022-2032 6.4.1. Solution 6.4.2. Suspension 6.4.3. Emulsion 6.4.4. Liposomes & Nanoparticles 6.4.5. Ointments 6.5. Market Attractiveness By Formulation Type 7. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Key Trends 7.4. Market Value Forecast By Disease Type, 2022-2032 7.4.1. Diabetic Retinopathy 7.4.2. Macular Degeneration 7.4.3. Cataract 7.4.4. Glaucoma 7.4.5. Diabetic Macular Edema 7.4.6. Dry Eye Syndrome 7.4.7. Others 7.5. Market Attractiveness By Disease Type 8. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By End User 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Key Trends 8.4. Market Value Forecast By End User, 2022-2032 8.4.1. Hospitals 8.4.2. Ambulatory Surgical Centers 8.4.3. Ophthalmic Clinics 8.4.4. Homecare Settings 8.5. Market Attractiveness By End User 9. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Region 9.1. Key Findings 9.2. Policies and Regulations 9.3. Market Value Forecast By Region 9.3.1. North America 9.3.2. Europe 9.3.3. Asia Pacific 9.3.4. Latin America 9.3.5. Middle East & Africa 9.4. Market Attractiveness By Country/Region 10. North America Ocular Drug Delivery Disease Type Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.1.2. Policies and Regulations 10.1.3. Price Trend Analysis 10.1.4. Key Trends 10.2. Market Value Forecast By Disease Type, 2022-2032 10.2.1. Topical 10.2.2. Ocular Insert 10.2.2.1. Erodible 10.2.2.2. Non-Erodible 10.2.3. Iontophoresis 10.2.4. Intraocular Implant 10.2.4.1. Biodegradable 10.2.4.2. Non-Biodegradable 10.2.5. In Situ Gel & Punctal Plug 10.2.6. Others 10.3. Market Value Forecast By Formulation Type, 2022-2032 10.3.1. Solution 10.3.2. Suspension 10.3.3. Emulsion 10.3.4. Liposomes & Nanoparticles 10.3.5. Ointments 10.4. Market Value Forecast By Disease Type, 2022-2032 10.4.1. Diabetic Retinopathy 10.4.2. Macular Degeneration 10.4.3. Cataract 10.4.4. Glaucoma 10.4.5. Diabetic Macular Edema 10.4.6. Dry Eye Syndrome 10.4.7. Others 10.5. Market Value Forecast By End User, 2022-2032 10.5.1. Hospitals 10.5.2. Ambulatory Surgical Centers 10.5.3. Ophthalmic Clinics 10.5.4. Homecare Settings 10.6. Market Value Forecast By Country, 2022-2032 10.6.1. U.S. 10.6.2. Canada 10.7. Market Attractiveness Analysis 10.7.1. By Disease Type 10.7.2. By Formulation Type 10.7.3. By Disease Type 10.7.4. By End User 10.7.5. By Country 11. Europe Ocular Drug Delivery Disease Type Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.1.2. Policies and Regulations 11.1.3. Price Trend Analysis 11.1.4. Key Trends 11.2. Market Value Forecast By Disease Type, 2022-2032 11.2.1. Topical 11.2.2. Ocular Insert 11.2.2.1. Erodible 11.2.2.2. Non-Erodible 11.2.3. Iontophoresis 11.2.4. Intraocular Implant 11.2.4.1. Biodegradable 11.2.4.2. Non-Biodegradable 11.2.5. In Situ Gel & Punctal Plug 11.2.6. Others 11.3. Market Value Forecast By Formulation Type, 2022-2032 11.3.1. Solution 11.3.2. Suspension 11.3.3. Emulsion 11.3.4. Liposomes & Nanoparticles 11.3.5. Ointments 11.4. Market Value Forecast By Disease Type, 2022-2032 11.4.1. Diabetic Retinopathy 11.4.2. Macular Degeneration 11.4.3. Cataract 11.4.4. Glaucoma 11.4.5. Diabetic Macular Edema 11.4.6. Dry Eye Syndrome 11.4.7. Others 11.5. Market Value Forecast By End User, 2022-2032 11.5.1. Hospitals 11.5.2. Ambulatory Surgical Centers 11.5.3. Ophthalmic Clinics 11.5.4. Homecare Settings 11.6. Market Value Forecast By Country, 2022-2032 11.6.1. U.K. 11.6.2. Germany 11.6.3. France 11.6.4. Italy 11.6.5. Russia 11.6.6. Spain 11.6.7. Rest of Europe 11.7. Market Attractiveness Analysis 11.7.1. By Disease Type 11.7.2. By Formulation Type 11.7.3. By Disease Type 11.7.4. By End User 11.7.5. By Country 12. Asia Pacific Ocular Drug Delivery Disease Type Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.1.2. Policies and Regulations 12.1.3. Price Trend Analysis 12.1.4. Key Trends 12.2. Market Value Forecast By Disease Type, 2022-2032 12.2.1. Topical 12.2.2. Ocular Insert 12.2.2.1. Erodible 12.2.2.2. Non-Erodible 12.2.3. Iontophoresis 12.2.4. Intraocular Implant 12.2.4.1. Biodegradable 12.2.4.2. Non-Biodegradable 12.2.5. In Situ Gel & Punctal Plug 12.2.6. Others 12.3. Market Value Forecast By Formulation Type, 2022-2032 12.3.1. Solution 12.3.2. Suspension 12.3.3. Emulsion 12.3.4. Liposomes & Nanoparticles 12.3.5. Ointments 12.4. Market Value Forecast By Disease Type, 2022-2032 12.4.1. Diabetic Retinopathy 12.4.2. Macular Degeneration 12.4.3. Cataract 12.4.4. Glaucoma 12.4.5. Diabetic Macular Edema 12.4.6. Dry Eye Syndrome 12.4.7. Others 12.5. Market Value Forecast By End User, 2022-2032 12.5.1. Hospitals 12.5.2. Ambulatory Surgical Centers 12.5.3. Ophthalmic Clinics 12.5.4. Homecare Settings 12.6. Market Value Forecast By Country, 2022-2032 12.6.1. China 12.6.2. Japan 12.6.3. India 12.6.4. Australia & New Zealand 12.6.5. Rest of Asia Pacific 12.7. Market Attractiveness Analysis 12.7.1. By Disease Type 12.7.2. By Formulation Type 12.7.3. By Disease Type 12.7.4. By End User 12.7.5. By Country 13. Latin America Ocular Drug Delivery Disease Type Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.1.2. Policies and Regulations 13.1.3. Price Trend Analysis 13.1.4. Key Trends 13.2. Market Value Forecast By Disease Type, 2022-2032 13.2.1. Topical 13.2.2. Ocular Insert 13.2.2.1. Erodible 13.2.2.2. Non-Erodible 13.2.3. Iontophoresis 13.2.4. Intraocular Implant 13.2.4.1. Biodegradable 13.2.4.2. Non-Biodegradable 13.2.5. In Situ Gel & Punctal Plug 13.2.6. Others 13.3. Market Value Forecast By Formulation Type, 2022-2032 13.3.1. Solution 13.3.2. Suspension 13.3.3. Emulsion 13.3.4. Liposomes & Nanoparticles 13.3.5. Ointments 13.4. Market Value Forecast By Disease Type, 2022-2032 13.4.1. Diabetic Retinopathy 13.4.2. Macular Degeneration 13.4.3. Cataract 13.4.4. Glaucoma 13.4.5. Diabetic Macular Edema 13.4.6. Dry Eye Syndrome 13.4.7. Others 13.5. Market Value Forecast By End User, 2022-2032 13.5.1. Hospitals 13.5.2. Ambulatory Surgical Centers 13.5.3. Ophthalmic Clinics 13.5.4. Homecare Settings 13.6. Market Value Forecast By Country, 2022-2032 13.6.1. Brazil 13.6.2. Mexico 13.6.3. Rest of Latin America 13.7. Market Attractiveness Analysis 13.7.1. By Disease Type 13.7.2. By Formulation Type 13.7.3. By Disease Type 13.7.4. By End User 13.7.5. By Country 14. Middle East & Africa Ocular Drug Delivery Disease Type Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.1.2. Policies and Regulations 14.1.3. Price Trend Analysis 14.1.4. Key Trends 14.2. Market Value Forecast By Disease Type, 2022-2032 14.2.1. Topical 14.2.2. Ocular Insert 14.2.2.1. Erodible 14.2.2.2. Non-Erodible 14.2.3. Iontophoresis 14.2.4. Intraocular Implant 14.2.4.1. Biodegradable 14.2.4.2. Non-Biodegradable 14.2.5. In Situ Gel & Punctal Plug 14.2.6. Others 14.3. Market Value Forecast By Formulation Type, 2022-2032 14.3.1. Solution 14.3.2. Suspension 14.3.3. Emulsion 14.3.4. Liposomes & Nanoparticles 14.3.5. Ointments 14.4. Market Value Forecast By Disease Type, 2022-2032 14.4.1. Diabetic Retinopathy 14.4.2. Macular Degeneration 14.4.3. Cataract 14.4.4. Glaucoma 14.4.5. Diabetic Macular Edema 14.4.6. Dry Eye Syndrome 14.4.7. Others 14.5. Market Value Forecast By End User, 2022-2032 14.5.1. Hospitals 14.5.2. Ambulatory Surgical Centers 14.5.3. Ophthalmic Clinics 14.5.4. Homecare Settings 14.6. Market Value Forecast By Country, 2022-2032 14.6.1. GCC Countries 14.6.2. South Africa 14.6.3. Rest of Middle East and Africa 14.7. Market Attractiveness Analysis 14.7.1. By Disease Type 14.7.2. By Formulation Type 14.7.3. By Disease Type 14.7.4. By End User 14.7.5. By Country 15. Competition Landscape 15.1. Market Player – Competition Matrix (By Tier and Size of companies) 15.2. Market Share Analysis By Company (2015) 15.3. Company Profiles 15.3.1. OCULAR THERAPEUTIX, INC. 15.3.1.1. Overview 15.3.1.2. Financials 15.3.1.3. Recent Developments 15.3.1.4. Strategy 15.3.2. Alimera Sciences 15.3.2.1. Overview 15.3.2.2. Financials 15.3.2.3. Recent Developments 15.3.2.4. Strategy 15.3.3. Allergan, Plc 15.3.3.1. Overview 15.3.3.2. Financials 15.3.3.3. Recent Developments 15.3.3.4. Strategy 15.3.4. Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Incorporated) 15.3.4.1. Overview 15.3.4.2. Financials 15.3.4.3. Recent Developments 15.3.4.4. Strategy 15.3.5. EyeGate Pharma 15.3.5.1. Overview 15.3.5.2. Financials 15.3.5.3. Recent Developments 15.3.5.4. Strategy 15.3.6. Envisia Therapeutics 15.3.6.1. Overview 15.3.6.2. Financials 15.3.6.3. Recent Developments 15.3.6.4. Strategy 15.3.7. Clearside Biomedical, INC. 15.3.7.1. Overview 15.3.7.2. Financials 15.3.7.3. Recent Developments 15.3.7.4. Strategy 15.3.8. Graybug Vision Inc. 15.3.8.1. Overview 15.3.8.2. Financials 15.3.8.3. Recent Developments 15.3.8.4. Strategy 15.3.9. Santen Pharmaceutical Co., Ltd 15.3.9.1. Overview 15.3.9.2. Financials 15.3.9.3. Recent Developments 15.3.9.4. Strategy 15.3.10. Taiwan Liposome Company, Ltd 15.3.10.1. Overview 15.3.10.2. Financials 15.3.10.3. Recent Developments 15.3.10.4. Strategy
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2022-2032
Table 02: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022-2032
Table 03: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, Intraocular Implants, 2022-2032
Table 04: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2022-2032
Table 05: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2022-2032
Table 06: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2022-2032
Table 07: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Region, 2022-2032
Table 08: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2022-2032
Table 09: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2022-2032
Table 10: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022-2032
Table 11: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2022-2032
Table 12: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2022-2032
Table 13: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2022-2032
Table 14: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2022-2032
Table 15: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2022-2032
Table 16: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2022-2032
Table 17: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022-2032
Table 18: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2022-2032
Table 19: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2022-2032
Table 20: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2022-2032
Table 21: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End Users, 2022-2032
Table 22: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2022-2032
Table 23: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2022-2032
Table 24: Asia Pacific Ocular Drug Delivery Technology Market, by Ocular Inserts, Market Size (US$ Mn) Forecast, 2022-2032
Table 25: Asia Pacific Ocular Drug Delivery Technology Market, by Intraocular Implants, Market Size (US$ Mn) Forecast, 2022-2032
Table 26: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2022-2032
Table 27: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2022-2032
Table 28: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End User, 2022-2032
Table 29: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2022-2032
Table 30: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2022-2032
Table 31: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022-2032
Table 32: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2022-2032
Table 33: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2022-2032
Table 34: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2022-2032
Table 35: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End Users, 2022-2032
Table 36: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2022-2032
Table 37: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2022-2032
Table 38: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022-2032
Table 39: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2022-2032
Table 40: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2022-2032
Table 41: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2022-2032
Table 42: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast, 2022-2032
Figure 2: Global Ocular Drug Delivery Technology Market Value Share, by Technology Type (2018)
Figure 3: Global Ocular Drug Delivery Technology Market Value Share, by Formulations Type (2018)
Figure 04: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type (2018)
Figure 05: Global Ocular Drug Delivery Technology Market Value Share, by Region (2018)
Figure 06: Global Ocular Drug Delivery Technology Market Value Share, by End-user (2018)
Figure 07: Global Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2022 and 2032
Figure 08: Global Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2022-2032
Figure 09: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Topical, 2022-2032
Figure 10: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ocular Inserts, 2022-2032
Figure 11: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Iontophoresis, 2022-2032
Figure 12: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intraocular Implants, 2022-2032
Figure 13: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by In Situ Gel & Punctal Plugs, 2022-2032
Figure 14: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Technology, 2022-2032
Figure 15: Global Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2022 and 2032
Figure 16: Global Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2022-2032
Figure 17: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Suspension, 2022-2032
Figure 18: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Solution, 2022-2032
Figure 19: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Liposome & Nanoparticle, 2022-2032
Figure 20: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Emulsion, 2022-2032
Figure 21: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Ointment, 2022-2032
Figure 22: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2022 and 2032
Figure 23: Global Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2022-2032
Figure 24: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Glaucoma, 2022-2032
Figure 25: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Retinopathy, 2022-2032
Figure 26: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Dry Eye Syndrome, 2022-2032
Figure 27: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Macular Degeneration, 2022-2032
Figure 28: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Macular Edema, 2022-2032
Figure 29: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cataract, 2022-2032
Figure 30: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2022-2032
Figure 31: Global Ocular Drug Delivery Technology Market Value Share, by End-user, 2022 and 2032
Figure 32: Global Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2022-2032
Figure 33: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2022-2032
Figure 34: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by ASCs, 2022-2032
Figure 35: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ophthalmic Clinics, 2022-2032
Figure 36: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Home Care Settings, 2022-2032
Figure 37: Global Ocular Drug Delivery Technology Market Value Share, by Region, 2022 and 2032
Figure 38: Global Ocular Drug Delivery Technology Market Attractiveness, by Region, 2022-2032
Figure 39: North America Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2032
Figure 40: North America Ocular Drug Delivery Technology Market Value Share, by Country, 2022 and 2032
Figure 41: North America Ocular Drug Delivery Technology Market Attractiveness, 2022-2032
Figure 42: North America Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2022 and 2032
Figure 43: North America Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2022-2032
Figure 44: North America Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2022 and 2032
Figure 45: North America Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2022-2032
Figure 46: North America Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2022 and 2032
Figure 47: North America Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2022-2032
Figure 48: North America Ocular Drug Delivery Technology Market Value Share, by End-user, 2022 and 2032
Figure 49: North America Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2022-2032
Figure 50: Europe Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022-2032
Figure 51: Europe Ocular Drug Delivery Technology Market Value Share, by Country, 2022 and 2032
Figure 52: Europe Ocular Drug Delivery Technology Market Attractiveness, by Country, 2022-2032
Figure 53: Europe Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2022 and 2032
Figure 54: Europe Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2022-2032
Figure 55: Europe Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2022 and 2032
Figure 56: Europe Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2022-2032
Figure 57: Europe Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2022 and 2032
Figure 58: Europe Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2022-2032
Figure 59: Europe Ocular Drug Delivery Technology Market Value Share, by End Users, 2022 and 2032
Figure 60: Europe Ocular Drug Delivery Technology Market Attractiveness, by End Users, 2022-2032
Figure 61: Asia Pacific Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2022-2032
Figure 62: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Country, 2022 and 2032
Figure 63: Asia Pacific Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2022-2032
Figure 64: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2022 and 2032
Figure 65: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2022-2032
Figure 66: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2022 and 2032
Figure 67: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2022-2032
Figure 68: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2022 and 2032
Figure 69: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2022-2032
Figure 70: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by End User, 2022 and 2032
Figure 71: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by End User, 2022-2032
Figure 72: Latin America Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2022-2032
Figure 73: Latin America Ocular Drug Delivery Technology Market Value Share, by Country, 2022 and 2032
Figure 74: Latin America Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2022-2032
Figure 75: Latin America Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2022 and 2032
Figure 76: Latin America Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2022-2032
Figure 77: Latin America Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2022 and 2032
Figure 78: Latin America Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2022-2032
Figure 79: Latin America Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2022 and 2032
Figure 80: Latin America Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2022-2032
Figure 81: Latin America Ocular Drug Delivery Technology Market Value Share, by End Users, 2022 and 2032
Figure 82: Latin America Ocular Drug Delivery Technology Market Attractiveness, by End Users, 2022-2032
Figure 83: Middle East & Africa Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2022-2032
Figure 84: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Country, 2022 and 2032
Figure 85: Middle East & Africa Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2022-2032
Figure 86: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2022 and 2032
Figure 87: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2022-2032
Figure 88: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2022 and 2032
Figure 89: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2022-2032
Figure 90: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2022 and 2032
Figure 91: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2022-2032
Figure 92: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by End-user, 2022 and 2032
Figure 93: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2022-2032
Figure 94: Global Ocular Drug Delivery Technology Market Share, by Company, 2021
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What was the market worth for Ocular Drug Delivery Technology in 2021?
As of 2021, Fact.MR estimated the Ocular Drug Delivery Technology market to have reached US$ 16.4 Billion
What is the expected worth of the Ocular Drug Delivery Technology industry in 2022?
By 2022, Fact.MR expected demand for Ocular Drug Delivery Technology to reach US$ 17.74 Billion
At what rate did the Ocular Drug Delivery Technology market flourish from 2015-2021?
From 2015-2021, the Ocular Drug Delivery Technology market grew at a 7.2% value CAGR
What is the expected forecast CAGR for Ocular Drug Delivery Technology from 2022-2032?
From 2022-2032, Ocular Drug Delivery Technology demand is likely to surge at a 8.4% CAGR
At what value will the market for Ocular Drug Delivery Technology close in 2032?
By 2032, the market for Ocular Drug Delivery Technology is likely to be valued at US$ 39 Billion
What is the expected market value for the U.S Ocular Drug Delivery Technology market?
By 2032, Fact.MR expects the U.S market for Ocular Drug Delivery Technology to reach US$ 9 Billion
How opportunistic is the Chinese market for Ocular Drug Delivery Technology?
China is expected to register a 7.3% CAGR with regard to the Ocular Drug Delivery Technology industry
What are the expected growth rates for the South Korean and Japanese markets?
South Korea and Japan are expected to document CAGRs worth 7.2% and 7.4% respectively in the Ocular Drug Delivery Technology market
Which Formulation type will account for the maximum Ocular Drug Delivery Technology revenue?
Solution-based Ocular Drug Delivery Technology will be maximum, expanding at a 7.7% CAGR
By Technology type, which category is likely to remain top-selling until 2032?
Intraocular Implants Ocular Drug Delivery Technology will remain most preferred, expanding at a CAGR of 8.2% until 2032
Ocular Drug Delivery Technology Market